Physician

Gavin Tanner Reed, M.D.

According to 2025 Medicare claims, Gavin Reed, M.D. (NPI: 1588013759) practices ophthalmology in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is RETINA SPECIALISTS OF NORTH ALABAMA LLC (NPI: 1194760652; TIN: 63-1248340) and primary practice location at 35801-4719. Reed is affiliated with the Huntsville ACO (ACO ID: A3579), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 995 traditional Medicare patients, billed 12,322 HCPCS/CPT codes, and received $1,514,029 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 337 prescription claims across 148 beneficiaries totaling $13,596 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $68. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,628 to $1,514,029. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,206 and ending at $13,596. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$757K$1.5M2020 Medicare payment: $7,628 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $11,173 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $245,574 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,188,221 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,514,029 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20205460$7,628
20217881$11,173
20224331,552$245,574
20238927,877$1,188,221
202499512,322$1,514,029

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.8K$18K2017 Drug cost: $5,206 (USD; Tot_Drug_Cst)2018 Drug cost: $1,915 (USD; Tot_Drug_Cst)2019 Drug cost: $2,725 (USD; Tot_Drug_Cst)2020 Drug cost: $4,996 (USD; Tot_Drug_Cst)2021 Drug cost: $2,881 (USD; Tot_Drug_Cst)2022 Drug cost: $4,047 (USD; Tot_Drug_Cst)2023 Drug cost: $17,589 (USD; Tot_Drug_Cst)2024 Drug cost: $13,596 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171630$5,206
2018N/R13$1,915
20191520$2,725
20202856$4,996
20211832$2,881
20224998$4,047
2023127294$17,589
2024148337$13,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2811,126$82
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more198198$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6691,034$55
92134Imaging of retina8922,077$25
92202Extended exam of the back part of the eye with optic nerve drawing402420$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1194,487$6,112
LumiganBimatoprost11300$2,861
Ketorolac TromethamineKetorolac Tromethamine30866$855
Gentamicin SulfateGentamicin Sulfate691,332$714
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat201,211$303

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$68Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gavin Tanner Reed, M.D.?

Tedicare shows public-source Medicare data for Gavin Tanner Reed, M.D. (NPI 1588013759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gavin Tanner Reed, M.D. have ACO affiliation data?

Gavin Tanner Reed, M.D. is shown with ACO affiliation data for Huntsville ACO (MSSP, ACO ID A3579).

What billing organization is linked to Gavin Tanner Reed, M.D.?

Gavin Tanner Reed, M.D. is linked to RETINA SPECIALISTS OF NORTH ALABAMA LLC (billing NPI 1194760652) in the available physician profile data.

Does Gavin Tanner Reed, M.D. have Open Payments data?

Gavin Tanner Reed, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.